inventages.com inventages.com

inventages.com

Inventages | Venture Capital

Transforming inventions into competitive advantages. Mar 9, 2018 - AM-Pharma still on track with sepsis drug despite mixed phase 2 readout. Mar 9, 2018 - AM-Pharma announces Phase II study results of recAP in sepsis-associated Acute Kidney Injury. Oct 4, 2017 - Phagenesis has successfully reached the first of two milestones in its staged acquisition agreement with Nestlé Health Science. May 31, 2017 - Atonomics announces CE marking of Trace Lipids Test Panel. Inventages, formed with the support of Nestlé...

http://www.inventages.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVENTAGES.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.9 out of 5 with 11 reviews
5 star
5
4 star
4
3 star
0
2 star
0
1 star
2

Hey there! Start your review of inventages.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1 seconds

CONTACTS AT INVENTAGES.COM

inventages venture capital GmbH

Gunnar Weikert

Franzis●●●●●●●asse 25

Ued●●●eim , 41468

DE

49.2●●●●4896
49.2●●●●4898
we●●●●●@inventages.com

View this contact

inventages venture capital GmbH

Gunnar Weikert

Franzis●●●●●●●asse 25

Ued●●●eim , 41468

DE

49.2●●●●4896
49.2●●●●4898
we●●●●●@inventages.com

View this contact

1&1 Internet AG

Hostmaster EINSUNDEINS

Brau●●●●. 48

Kar●●●uhe , 76135

DE

49.●●●600
49.72●●●●●74248
ho●●●●●●●●@1und1.de

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2000 November 19
UPDATED
2013 November 20
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 23

    YEARS

  • 5

    MONTHS

  • 7

    DAYS

NAME SERVERS

1
ns11.schlund.de
2
ns12.schlund.de

REGISTRAR

1 & 1 INTERNET AG

1 & 1 INTERNET AG

WHOIS : whois.schlund.info

REFERRED : http://1and1.com

CONTENT

SCORE

6.2

PAGE TITLE
Inventages | Venture Capital | inventages.com Reviews
<META>
DESCRIPTION
Transforming inventions into competitive advantages. Mar 9, 2018 - AM-Pharma still on track with sepsis drug despite mixed phase 2 readout. Mar 9, 2018 - AM-Pharma announces Phase II study results of recAP in sepsis-associated Acute Kidney Injury. Oct 4, 2017 - Phagenesis has successfully reached the first of two milestones in its staged acquisition agreement with Nestlé Health Science. May 31, 2017 - Atonomics announces CE marking of Trace Lipids Test Panel. Inventages, formed with the support of Nestlé...
<META>
KEYWORDS
1 about us
2 team
3 portfolio
4 news
5 focus
6 careers
7 select page
8 justus homburg
9 paul hartung
10 ceo cognoptix
CONTENT
Page content here
KEYWORDS ON
PAGE
about us,team,portfolio,news,focus,careers,select page,justus homburg,paul hartung,ceo cognoptix,charles stacey,ceo accera,nassau,caves village,office #4,london,dartmouth street
SERVER
Apache
POWERED BY
PHP/7.0.28
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Inventages | Venture Capital | inventages.com Reviews

https://inventages.com

Transforming inventions into competitive advantages. Mar 9, 2018 - AM-Pharma still on track with sepsis drug despite mixed phase 2 readout. Mar 9, 2018 - AM-Pharma announces Phase II study results of recAP in sepsis-associated Acute Kidney Injury. Oct 4, 2017 - Phagenesis has successfully reached the first of two milestones in its staged acquisition agreement with Nestlé Health Science. May 31, 2017 - Atonomics announces CE marking of Trace Lipids Test Panel. Inventages, formed with the support of Nestlé...

INTERNAL PAGES

inventages.com inventages.com
1

GC-Rise’s 2014 results confirm that growth trend remains solid, and well positioned to achieve increased market share in 2015 | Inventages

http://www.inventages.com/gc-rises-2014-results-confirm-that-growth-trend-remains-solid-and-well-positioned-to-achieve-increased-market-share-in-2015

GC-Rise’s 2014 results confirm that growth trend remains solid, and well positioned to achieve increased market share in 2015. Feb 27, 2015. A leading pharmaceutical company focused on women and children’s healthcare in China, announced its results for 2014: their revenue reached $46 million and it is estimated to keep the yearly growth trend by over 30% projecting $61 million for 2015. Proven strength of commercialization capabilities. New online-to-offline (O2O) platform. Inventages featured In Bloombe...

2

accera | Inventages

http://www.inventages.com/project/accera

Accera’s proprietary therapeutic platform addresses the established physiological hallmark and metabolic defect of decreased cerebral glucose metabolism (DCGM) in neurodegenerative diseases such as Alzheimer’s. Proprietary mechanism of action. Accera’s core technology is to induce a mild state of ketosis in patients with AD. Ketosis is characterized by the presence of ketone bodies in the blood. Under conditions of low glucose availability, such as during a fast, the body taps fat reserves to gen.

3

Pfizer strikes $600m deal with AM Pharma, an Inventages portfolio company | Inventages

http://www.inventages.com/pfizer-acquires-minority-interest-in-am-pharma-secures-option-to-acquire-company

Pfizer strikes $600m deal with AM Pharma, an Inventages portfolio company. May 12, 2015. Option may be exercised based on Phase II trial results for. Recombinant human Alkaline Phosphatase. Ropes and Gray LLP and De Brauw Blackstone Westbroek N.V. acted as legal advisors to Pfizer, and Dechert LLP and Clifford Chance LLP acted as legal advisors to AM-Pharma. Erik van den Berg (CEO). 31 30 259 8838. 44 777 588 1813. Dean Mastrojohn, 212-733-6944. Ryan Crowe, 212-733-8160. Accera Completes Enrollment of Ph...

4

Vital Foods Completes Recruitment for the IDEA Trial, a Phase 3 Trial of Zyactinase® in IBS-C | Inventages

http://www.inventages.com/vital-foods-completes-recruitment-for-the-idea-trial-a-phase-3-trial-of-zyactinase-in-ibs-c

Vital Foods Completes Recruitment for the IDEA Trial, a Phase 3 Trial of Zyactinase in IBS-C. May 4, 2015. New Zealand natural pharmaceutical company Vital Food Processors Ltd announced the completion of patient enrolment for its IDEA Trial, a Phase 3 trial investigating the role of the company’s kiwifruit extract Zyactinase in alleviating the symptoms associated with Constipation-predominant Irritable Bowel Syndrome (IBS-C). Detailed final results of the IDEA trial are expected before the end of the year.

5

am-pharma | Inventages

http://www.inventages.com/project/am-pharma

Developing the first therapeutic for Acute Kidney Injury and first oral biologic for IBD. AM Pharma develops novel recombinant human alkaline phosphatase (AP) therapeutics, which have the potential to be first-in-class medicines and transform the treatment prospects for patients with chronic or life-threatening inflammatory diseases. Proprietary recombinant human alkaline phosphatase platform (recAP). Funded Phase II recAP program to build on strong existing clinical and safety data. In moderate-severe U...

UPGRADE TO PREMIUM TO VIEW 14 MORE

TOTAL PAGES IN THIS WEBSITE

19

LINKS TO THIS WEBSITE

xolution.com xolution.com

Shareholder

http://www.xolution.com/shareholder.html

Solutions For the Generation on the Go. Is major shareholder of XOLUTION since beginning of 2016. Inventure brings to XOLUTION an extensive manufacturing experience from the aluminum can and plastics industry. Its focus is on packaging solutions and more specifically with multinational beverage companies and brands in its portfolio. Is based in Regensburg and was the inventor company of the XO-100. Since that time, they are shareholder of XOLUTION. For further information, please contact us at:.

nanoinitiative-bayern.de nanoinitiative-bayern.de

Cluster Beirat: Nanoinitiative Bayern GmbH

http://www.nanoinitiative-bayern.de/cluster-beirat.html

Forschung und Lehre in Bayern. Ausgewählte Netzwerke und Projekte. Nanonetz Bayern e.V. Unseren aktuellen Newsletter als PDF herunter. Nanotech Cluster SME Mission des EU-Japan Centre for Industrial Cooperation vom 13.-17.02.2017 nach Tokio/Japan. Neue BMBF-Fördermaßnahme KMU-NetC fördert strategische KMU-Innovationsverbünde in Netzwerken und Clustern. Wann ist Nano sicher? Neue Broschüre zum Thema Nanosicherheit. Clustergemeinschaftsstand auf Messe nano tech vom 15.-17.02.2017 in Tokio/Japan. Geschäftsf...

directcapital.co.nz directcapital.co.nz

Direct Capital

http://directcapital.co.nz/BioPacificVentures.aspx

This content requires the Adobe Flash Player, Get Flash. BioPacificVentures is one of the world's largest food, nutrition and agriculturally focused venture capitalists, specialising in the convergence of food and health with a focus on prevention, nutrition, food technology and agbiotech. BioPacificVentures pursues attractive life science investment opportunities with an Australasian focus and takes lead or co-investment positions in rounds ranging from NZ$2 to NZ$10 million. And one of the world’s lead...

directcapital.co.nz directcapital.co.nz

Direct Capital

http://directcapital.co.nz/History.aspx

This content requires the Adobe Flash Player, Get Flash. Direct Capital was established in 1994 and is owned by its executives who have been together since its first fund. We manage investment into private companies which, by their nature, are difficult for the wider community of investors to access independently. In our 20 year history we have raised and managed more than $800 million through 7 funds, including three affiliate programmes. Our affiliate programmes were established with joint venture part...

UPGRADE TO PREMIUM TO VIEW 11 MORE

TOTAL LINKS TO THIS WEBSITE

15

OTHER SITES

inventage.com inventage.com

Inventage

Inventage entwickelt und implementiert massgeschneiderte IT-Lösungen. Firmen mit innovativen Ansätzen und komplexen Anforderungen sind unsere Kunden.

inventage.fr inventage.fr

Inventage – Générateur de performance durable

Finance and Gestion des charges immobilières. RH and Coût du travail. Inventage est un groupe. Économique pour les entreprises. Politique environnementale, charges sociales, déclarations fiscales Nos 80 spécialistes, consultants et ingénieurs vous aident à développer de nouvelles sources de rentabilité grâce à un savoir-faire sans cesse actualisé, une veille juridique de pointe et un accompagnement sur l’ensemble de vos démarches. Générateur de performance durable pour les entreprises. Évoluant depuis 20...

inventage.nl inventage.nl

Inventage ICT diensten - Uw partner in de ICT

ICT Beheer and Support. Inventage adviseert en ondersteunt al ruim 10 jaar zowel commerciële bedrijven als non-profit organisaties op het gebied van de ICT. ICT is tegenwoordig een belangrijke factor binnen de bedrijfsvoering en dient dan ook als zodanig benaderd te worden. Met het door ons zelf ontwikkelde kwaliteitsbeheersysteem, de gespecialiseerde kennis en onze hoge service zijn wij in staat ons uitgebreide pakket geheel af te stemmen op elke omgeving. Een kleine greep uit de diensten en producten:.

inventage.one2team.com inventage.one2team.com

OpenID transaction in progress

inventage.pl inventage.pl

Inventage — Zwiększymy Twój Zysk!

22 266 84 44. Lider ulepszania wyników finansowych. Składka na ubezpieczenie wypadkowe nowe stopy procentowe. Ministerstwo Rodziny, Pracy i Polityki Społecznej zgłosiło projekt zmiany rozporządzenia w sprawie różnicowania stopy procentowej składki na ubezpieczenie społeczne z tytułu wypadków przy Czytaj więcej. Gala CCIFP 2018 Champagne. Prezes Inventage Alain Kaj wraz z Dyrektor Działu VAT Beatą Złotek obecni byli na dorocznej gali Francusko-Polskiej Izby Gospodarczej. Doroczna Gala Czytaj więcej. Ta st...

inventages.com inventages.com

Inventages | Venture Capital

Transforming inventions into competitive advantages. Mar 9, 2018 - AM-Pharma still on track with sepsis drug despite mixed phase 2 readout. Mar 9, 2018 - AM-Pharma announces Phase II study results of recAP in sepsis-associated Acute Kidney Injury. Oct 4, 2017 - Phagenesis has successfully reached the first of two milestones in its staged acquisition agreement with Nestlé Health Science. May 31, 2017 - Atonomics announces CE marking of Trace Lipids Test Panel. Inventages, formed with the support of Nestlé...

inventagiochi.blogspot.com inventagiochi.blogspot.com

l'Inventagiochi

Lunedì 11 giugno 2012. Ormai le uova a casa mia si svuotano. Soffiando dai buchi e i gusci diventano,. Per i miei bimbi,. Uno dei supporti principali. Dopo gli scarti dei miei legnetti). Questa volta i gusci delle uova sono. Diventati i gusti di un buonissimo. Gelato.fragola,cioccolato e stracciatella. C'è poi chi è così goloso che vuole anche la panna. Creata con tovaglioli tagliati a spirale e poi. Ricomposti a modo di panna. Lui, invece lo preferisce senza. Ed è l'ideatore del cono. Slurp, che buono!

inventagiovani.it inventagiovani.it

Shell InventaGIOVANI - Benvenuti a Shell InventaGIOVANI

Per avere contatti utili con altri imprenditori. Per fare domande e risposte nel forum di discussione. Per promuovere la tua impresa sul social network. Per sapere cosa succede intorno a te. Per partecipare ad eventi rilevanti. Per essere al centro delle informazioni. Per sapere cosa offre il programma InventaGIOVANI. Per partecipare agli appuntamenti formativi. Per avere un riferimento e una guida nelle fasi iniziali della tua impresa. Benvenuti a Shell InventaGIOVANI. Per questo motivo InventaGIOVANI, ...

inventagon.com inventagon.com

Inventagon - Innovate. Patent. Prosper.

Follow us on Twitter. Become a Fan on Facebook. We’ve taken care of the innovative technology and its patent so you can make it a success. How? There are inventions that capture the imagination. And then there are inventions that capture the market. Inventagon’s inventions do both. We assist clients in all industries who are looking for strategic growth through market-ready technology that can deliver a competitive edge.

inventagora.com inventagora.com

www.inventagora.com

This Web page parked FREE courtesy of FirmExcel eShop. Search for domains similar to. Is this your domain? Let's turn it into a website! Would you like to buy this. Find Your Own Domain Name. See our full line of products. Easily Build Your Professional Website. As low as $6.90/mo. Call us any time day or night (480) 624-2500.

inventagous.com inventagous.com

Enabling Creativity